Security key
004890109
Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (ACRV)
CUSIP: 004890109
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 18,610,735
- Total 13F value
- $44,851,327
- Share change
- +1,108,082
- SEC-reported price per share
- $2.41
- Number of holders
- 48
- Value change
- +$2,731,349
- Number of buys
- 24
- Number of sells
- 15
- Shares outstanding
- 43,193,792
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
48
Top holders
10
ACRV full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Acrivon Therapeutics, Inc. SEC filings
Acrivon Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 004890109
Recent filing periods:
Ownership snapshot
Top reported holders of ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Chione Ltd
Disclosed value leader
Chione Ltd
Comparable rows
0/15
Latest evidence
30 Sep 2025
3/4/5
13F
Highest disclosed value: $16,741,549
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Chione Ltd has the largest disclosed position value at $16.74M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Chione Ltd's linked filing trail.
Disclosed position value
Top 5
Chione Ltd
$16.74M
PERCEPTIVE ADVISORS LLC
$4.16M
Wellington Biomedical Innovation ...
$3.86M
RA CAPITAL MANAGEMENT, L.P.
$15.1M
Sands Capital Alternatives, LLC
$3.84M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Chione Ltd |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$16,741,549
3,848,632 shares
|
— | 26 Jun 2023 |
| PERCEPTIVE ADVISORS LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$4,159,546
3,104,139 shares
|
— | 30 Apr 2025 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$3,863,366
888,130 shares
|
— | 17 Nov 2022 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
—
denominator unverified
|
$15,096,319
8,340,508 shares
|
— | 30 Sep 2025 |
| Sands Capital Alternatives, LLC |
13F
Company
|
—
denominator unverified
|
$3,841,915
2,122,605 shares
|
— | 30 Sep 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$2,789,800
1,541,326 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
48
Shares
18,610,735
Rows available
48
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
45
Q4 2025 holders
48
Holder diff
3
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend